Integer Holdings ITGR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Sales by Product | ||||||
| Cardiac Rhythm Management & Neuromodulation | $676.72M+1.9% | $668.8M+1.2% | $672.02M+4.3% | $667.96M+4.5% | $664.02M+6.3% | |
| Other Markets | $69.16M-27.6% | $77.75M-26.9% | $80.88M-26.0% | $84.81M-23.3% | $95.57M-12.2% | |
| Long-Lived Assets by Geography | ||||||
| Ireland | $633.3M— | $623.46M— | $602.83M— | —— | —— | |
| Mexico | $176.21M— | $169.07M— | $160.99M— | —— | —— | |
| Rest of world | $124.12M— | $123.5M— | $118.8M— | —— | —— | |
| United States | $1.16B— | $1.15B— | $1.11B— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Integer Holdings break its business down?
- Integer Holdings (ITGR) reports total sales by product across 3 parts — Cardiac Rhythm Management & Neuromodulation, Cardio & Vascular and Other Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Integer Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integer Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
